Additional medicines across our portfolio supporting a broad range of patient needs.
Our Portfolio
5 products in this therapeutic area
Product information is intended for healthcare professionals. Please refer to the approved prescribing information for full details of indications, dosage and safety.
Manufactured under cGMP
Aligned to SFDA, PIC/S, ISO and WHO standards
Supported by our Pharmacovigilance team
Valencin
Valencin® Indication: Treatment of complicated skin and soft tissue infections, Staphylococcus aureus bloodstream infections (bacteremia), and right-sided infective endocarditis in adults. Strength: 500 mg Dosage Form: Powder for Solution for Injection or Infusion Active Ingredient: Daptomycin
Zoledronic Acid SPC
Zoledronic Acid SPC® Indication: Prevention of skeletal-related events in adults with bone metastases and treatment of tumor-induced hypercalcemia (TIH). Strengths: 4 mg/100 ml, 5 mg/100 ml Dosage Form: Vial for Injection Active Ingredient: Zoledronic Acid Monohydrate
RENAPAT
RENAPAT® Indication: Treatment of hyperphosphatemia in adults with chronic kidney disease, including patients on dialysis. Strength: 800 mg Dosage Form: Film-Coated Tablets Active Ingredient: Sevelamer Carbonate
Colistimethate SPC
Colistimethate SPC® Indication: Treatment of serious bacterial infections when other antibiotics are not suitable. Strength: 1 Million IU Dosage Form: Powder for Solution for Injection or Infusion Active Ingredient: Colistimethate Sodium
Fosaprepitant SPC
Fosaprepitant SPC® Indication: Prevention of chemotherapy-induced nausea and vomiting (CINV) in adults and pediatric patients ≥6 months. Strength: 150 mg Dosage Form: Vial for Injection Active Ingredient: Fosaprepitant
Manufactured to international standards
Every product in this portfolio is made under cGMP, in facilities aligned to SFDA, PIC/S, ISO and WHO expectations.
Enquiries
Looking for product information?
Our medical and regulatory teams can support healthcare professionals with product enquiries and prescribing information.